A comparison of the efficacy and safety of complementary and alternative therapies for premature ovarian insufficiency
Authors:
Open Access
- 31 July 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (31) , e21538
Abstract
Background: With the increase in the incidence of premature ovarian insufficiency (POI) over the years, the ovarian function has become one of the integral aspects of research in reproductive medicine today. POI seriously affects the physical and mental health of women, especially reproductive health. Studies show both complementary and alternative therapies to be effective in treating POIs. However, consistency in conclusions is still far-fetched. In light of this, we will carry out a study to evaluate the effectiveness and safety of complementary and alternative therapies for POIs. We therefore develop a study protocol for a proposed network meta-analysis (NMA) and systematic review on POI. Methods: The following electronic bibliographic database will be searched: VIP database, Wanfang database, Chinese National Knowledge Infrastructure (CNKI), The Cochrane Library, PubMed, EMBASE and Web of Science from inception till 31 December 2019. A search at the World Health Organization (WHO) International Clinical Trials Registry Platform will also be done. Subsequently, the searched data will undergo independent screening, retrieving, and risk of bias assessment by 2 reviewers. Analysis will be performed on included studies using the NMA technique. Next, the primary outcomes will be compared using ADDIS 1.16.5 and Stata 15.0. Results: The safety and effectiveness of alternative and complementary therapies used in the treatment of POI will be compared and evaluated. Conclusion: This work will provide high-quality evidence for clinicians in the field to build on for best practices in effective interventions (complementary and alternative therapies) for POI. Ethics and dissemination: This NMA is a secondary research which based on some previously published data. Therefore, the ethical approval was not necessary. PROSPERO registration number: CRD42020163873Keywords
Funding Information
- Shandong Key R&D Program (2015GSF119028)
- TCM science & technology development plan project of Shandong province (No. 2019-0134)
This publication has 26 references indexed in Scilit:
- The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safetyFrontiers in Pharmacology, 2014
- Cytogenetic analysis of 531 Chinese women with premature ovarian failureHuman Reproduction, 2012
- The Legal and Regulatory Framework of Herbal Medicinal Products in the European Union: A Focus on the Traditional Herbal Medicines CategoryDrug Information Journal, 2011
- Non-hormonal interventions for hot flushes in women with a history of breast cancerCochrane Database of Systematic Reviews, 2010
- An immunological insight into premature ovarian failure (POF)Autoimmunity Reviews, 2010
- Primary ovarian insufficiencyThe Lancet, 2010
- Perceptions, use and attitudes of pharmacy customers on complementary medicines and pharmacy practiceBMC Complementary and Alternative Medicine, 2010
- Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trialBMC Complementary and Alternative Medicine, 2010
- European Legislation on Herbal MedicinesDrug Safety, 2008
- Trends in Alternative Medicine Use in the United States, 1990-1997JAMA, 1998